Over the past 3 decades, compounds called selective estrogen receptor modulators 
(SERMs) have been developed that block the estrogen receptor in some tissues 
(estrogen receptor antagonists) or stimulate the estrogen receptor in other 
tissues (estrogen receptor agonists). This Practice Pearl focuses on SERMs that 
clinicians can use for menopausal patients.